Alerus Financial’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.96M | Sell |
7,899
-760
| -9% | -$365K | 0.17% | 73 |
|
|
2026
Q1 | $4.26M | Sell |
8,659
-497
| -5% | -$270K | 0.21% | 69 |
|
|
2025
Q4 | $5.31M | Buy |
9,156
+3,968
| +76% | +$2.24M | 0.26% | 62 |
|
|
2025
Q3 | $2.52M | Buy |
5,188
+3,106
| +149% | +$1.45M | 0.13% | 102 |
|
|
2025
Q2 | $844K | Sell |
2,082
-214
| -9% | -$89.5K | 0.06% | 116 |
|
|
2025
Q1 | $1.14M | Sell |
2,296
-93
| -4% | -$50.4K | 0.09% | 108 |
|
|
2024
Q4 | $1.24M | Sell |
2,389
-7,158
| -75% | -$3.94M | 0.1% | 102 |
|
|
2024
Q3 | $5.91M | Buy |
9,547
+1,055
| +12% | +$625K | 0.43% | 57 |
|
|
2024
Q2 | $4.7M | Sell |
8,492
-28
| -0.3% | -$16K | 0.35% | 66 |
|
|
2024
Q1 | $4.95M | Sell |
8,520
-232
| -3% | -$130K | 0.37% | 64 |
|
|
2023
Q4 | $4.65M | Sell |
8,752
-1,530
| -15% | -$741K | 0.38% | 66 |
|
|
2023
Q3 | $5.2M | Sell |
10,282
-746
| -7% | -$398K | 0.46% | 59 |
|
|
2023
Q2 | $5.75M | Sell |
11,028
-594
| -5% | -$321K | 0.49% | 59 |
|
|
2023
Q1 | $6.7M | Buy |
11,622
+30
| +0.3% | +$16.9K | 0.6% | 49 |
|
|
2022
Q4 | $6.38M | Buy |
11,592
+1,011
| +10% | +$536K | 0.58% | 45 |
|
|
2022
Q3 | $5.37M | Buy |
10,581
+3,602
| +52% | +$2.02M | 0.53% | 52 |
|
|
2022
Q2 | $3.79M | Sell |
6,979
-2,613
| -27% | -$1.44M | 0.35% | 68 |
|
|
2022
Q1 | $5.67M | Buy |
9,592
+242
| +3% | +$139K | 0.48% | 53 |
|
|
2021
Q4 | $6.24M | Buy |
9,350
+246
| +3% | +$154K | 0.51% | 40 |
|
|
2021
Q3 | $5.2M | Sell |
9,104
-88
| -1% | -$48.3K | 0.47% | 46 |
|
|
2021
Q2 | $4.64M | Sell |
9,192
-426
| -4% | -$201K | 0.47% | 55 |
|
|
2021
Q1 | $4.39M | Sell |
9,618
-758
| -7% | -$362K | 0.46% | 58 |
|
|
2020
Q4 | $4.83M | Buy |
10,376
+1,134
| +12% | +$532K | 0.49% | 52 |
|
|
2020
Q3 | $4.08M | Sell |
9,242
-4,908
| -35% | -$2.03M | 0.46% | 55 |
|
|
2020
Q2 | $5.13M | Buy |
14,150
+40
| +0.3% | +$13.4K | 0.6% | 41 |
|
|
2020
Q1 | $4M | Buy |
14,110
+1,937
| +16% | +$611K | 0.55% | 54 |
|
|
2019
Q4 | $3.96M | Sell |
12,173
-240
| -2% | -$72.8K | 0.45% | 65 |
|
|
2019
Q3 | $3.62M | Sell |
12,413
-224
| -2% | -$64.1K | 0.47% | 65 |
|
|
2019
Q2 | $3.71M | Sell |
12,637
-460
| -4% | -$127K | 0.5% | 54 |
|
|
2019
Q1 | $3.58M | Sell |
13,097
-136
| -1% | -$33.8K | 0.5% | 56 |
|
|
2018
Q4 | $2.96M | Buy |
+13,233
| New | +$3.1M | 0.45% | 60 |
|
Other funds holding TMO
Alerus Financial's TMO Position: Q2 2026 in Review
Alerus Financial reduced its Thermo Fisher Scientific (TMO) stake by 8.8% in Q2 2026, selling an estimated $365K and leaving 7,899 shares worth $3.96M. The position accounts for 0.17% of the portfolio, ranked #73.
Alerus Financial first reported a position in TMO in Q4 2018 and has held it in 31 quarters since. The position peaked at $6.7M in Q1 2023. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Alerus Financial held 7,899 shares of Thermo Fisher Scientific worth $3.96M as of Q2 2026.
- Alerus Financial sold 760 Thermo Fisher Scientific shares in Q2 2026, an estimated $365K.
- Thermo Fisher Scientific made up 0.17% of Alerus Financial's portfolio in Q2 2026, its #73 holding.
- Alerus Financial first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 31 quarters since.
- Alerus Financial's Thermo Fisher Scientific position peaked at $6.7M in Q1 2023.
- 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Alerus Financial's 13F filing for Q2 2026, filed 14 Aug 2026.